[Federal Register: January 21, 2003 (Volume 68, Number 13)]
[Notices]
[Page 2784]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr21ja03-69]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Vaccines and Related Biological Products Advisory Committee;
Notice of Meeting
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
This notice announces a forthcoming meeting of a public advisory
committee of the Food and Drug Administration (FDA). At least one
portion of the meeting will be closed to the public.
Name of Committee: Vaccines and Related Biological Products
Advisory Committee.
General Function of the Committee: To provide advice and
recommendations to the agency on FDA's regulatory issues.
Date and Time: The meeting will be held on February 20, 2003, from
8:30 a.m. to 4:30 p.m.
Location: Holiday Inn, 8120 Wisconsin Ave., Bethesda, MD.
Contact Person: Jody G. Sachs or Denise H. Royster, Center for
Biologics Evaluation and Research (HFM-71), Food and Drug
Administration, 1401 Rockville Pike, Rockville, MD 20852, 301-827-0314,
or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-
0572 in the Washington, DC area), code 12391. Please call the
Information Line for up-to-date information on this meeting.
Agenda: The committee will review and discuss the selection of
strains to be included in the influenza virus vaccine for the 2003-2004
season and the intramural research program of the Laboratory of
Bacterial Polysaccharides, Office of Vaccines Research and Review.
Procedure: On February 20, 2003, from 8:30 a.m. to 3:20 p.m., the
meeting is open to the public. Interested persons may present data,
information, or views, orally or in writing, on issues pending before
the committee. Written submissions may be made to the contact person by
February 4, 2003. Oral presentations from the public will be scheduled
between approximately 1 p.m. and 1:30 p.m. and 2:50 p.m. and 3:20 p.m.
Time allotted for each presentation may be limited. Those desiring to
make formal oral presentations should notify the contact person before
February 4, 2003, and submit a brief statement of the general nature of
the evidence or arguments they wish to present, the names and addresses
of proposed participants, and an indication of the approximate time
requested to make their presentation.
Closed Committee Deliberations: On February 20, 2003, from 3:20
p.m. to 4:30 p.m., the meeting will be closed to permit discussion
where disclosure would constitute a clearly unwarranted invasion of
personal privacy (5 U.S.C. 552b(c)(6)).
Persons attending FDA's advisory committee meetings are advised
that the agency is not responsible for providing access to electrical
outlets.
FDA welcomes the attendance of the public at its advisory committee
meetings and will make every effort to accommodate persons with
physical disabilities or special needs. If you require special
accommodations due to a disability, please contact Jody G. Sachs or
Denise H. Royster at least 7 days in advance of the meeting.
Notice of this meeting is given under the Federal Advisory
Committee Act (5 U.S.C. app. 2).
Dated: January 10, 2003.
Linda Arey Skladany,
Associate Commissioner for External Relations.
[FR Doc. 03-1208 Filed 1-17-03; 8:45 am]
BILLING CODE 4160-01-S